LEAVENS, STRAND, GLOVER & ADLER, LLC

We are a full-service intellectual property, corporate and Regulatory compliance law firm with experience helping entrepreneurs, create, license and protect their businesses.

The cannin report is a quarterly newsletter and exclusive member dashboard curated by industry experts. We only offer you useful resources and freebies.

Subscribe and receive an invite to the cannin report.

From the cannin blog.

December 18, 2018 in Finance

Veritas Raises $1.56 Million in Private Placement

Vancouver, Canada-based medical cannabis science firm Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:…
Read More
December 17, 2018 in Acquisition, Expansion, Finance

Veritas Buys 25% of Cannabis Grow Facility in British Columbia

Vancouver, Canada-based medical cannabis science firm Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:…
Read More
December 17, 2018 in Finance, Legalization

Cronos, Canopy Growth, Tilray, & Cannabis Sativa Set to Ride Wave of New Era of CBD Sales

The 2018 Farm Bill will effectively legalize hemp and make it an agricultural commodity that…
Read More
December 17, 2018 in Medical, Partnership

Wayland Group Buys into UK Medical Cannabis Firm, Theros

Toronto and Munich-based Wayland Group (formerly Maricann) (CSE:WAYL) (OTCQB:MRRCF) agreed to buy 51% of UK-based Theros Pharma…
Read More
December 18, 2018 in Finance

Veritas Raises $1.56 Million in Private Placement

Vancouver, Canada-based medical cannabis science firm Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:…
Read More
December 17, 2018 in Acquisition, Expansion, Finance

Veritas Buys 25% of Cannabis Grow Facility in British Columbia

Vancouver, Canada-based medical cannabis science firm Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:…
Read More
December 17, 2018 in Finance, Legalization

Cronos, Canopy Growth, Tilray, & Cannabis Sativa Set to Ride Wave of New Era of CBD Sales

The 2018 Farm Bill will effectively legalize hemp and make it an agricultural commodity that…
Read More
December 17, 2018 in Medical, Partnership

Wayland Group Buys into UK Medical Cannabis Firm, Theros

Toronto and Munich-based Wayland Group (formerly Maricann) (CSE:WAYL) (OTCQB:MRRCF) agreed to buy 51% of UK-based Theros Pharma…
Read More
December 18, 2018 in Finance

Veritas Raises $1.56 Million in Private Placement

Vancouver, Canada-based medical cannabis science firm Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:…
Read More
December 17, 2018 in Acquisition, Expansion, Finance

Veritas Buys 25% of Cannabis Grow Facility in British Columbia

Vancouver, Canada-based medical cannabis science firm Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:…
Read More
December 17, 2018 in Finance, Legalization

Cronos, Canopy Growth, Tilray, & Cannabis Sativa Set to Ride Wave of New Era of CBD Sales

The 2018 Farm Bill will effectively legalize hemp and make it an agricultural commodity that…
Read More
December 17, 2018 in Medical, Partnership

Wayland Group Buys into UK Medical Cannabis Firm, Theros

Toronto and Munich-based Wayland Group (formerly Maricann) (CSE:WAYL) (OTCQB:MRRCF) agreed to buy 51% of UK-based Theros Pharma…
Read More
December 18, 2018 in Finance

Veritas Raises $1.56 Million in Private Placement

Vancouver, Canada-based medical cannabis science firm Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:…
Read More
December 17, 2018 in Acquisition, Expansion, Finance

Veritas Buys 25% of Cannabis Grow Facility in British Columbia

Vancouver, Canada-based medical cannabis science firm Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:…
Read More
December 17, 2018 in Finance, Legalization

Cronos, Canopy Growth, Tilray, & Cannabis Sativa Set to Ride Wave of New Era of CBD Sales

The 2018 Farm Bill will effectively legalize hemp and make it an agricultural commodity that…
Read More
December 17, 2018 in Medical, Partnership

Wayland Group Buys into UK Medical Cannabis Firm, Theros

Toronto and Munich-based Wayland Group (formerly Maricann) (CSE:WAYL) (OTCQB:MRRCF) agreed to buy 51% of UK-based Theros Pharma…
Read More